News

logo et courbe des catégory quantel medical

Sort by :

12/6/19

VITRA 2 receives approval from the FDA

VITRA 2 receives approval from the FDA

Quantel Medical announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for the Vitra 2® photocoagulator.

8/26/19

ACQUISITION OF THE COMPANY OPTOTEK MEDICAL

ACQUISITION OF THE COMPANY OPTOTEK MEDICAL

Quantel Medical announces the acquisition of the Slovenian company Optotek Medical d.o.o., specialised in the development of optical solutions and lasers for medical applications.

5/29/19

LacryStim: CE mark approval

LacryStim: CE mark approval

Quantel Medical today announced the CE mark approval of LacryStimTM IPL system. Based on intense pulsed light technology, LacryStimTM is used for the treatment of dry eye diseases such as Meibomian gland dysfunction.

3/27/19

ABSolu: FDA Approval

ABSolu: FDA Approval

Quantel Medical today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on March 25, 2019 for the New A/B/S Ultrasound Platform: ABSolu®